Name
DRONCIT 50 MG TABLETS FOR DOGS AND CATS
Pharmacotherapeutic Category
Anthelmintics.
Active Ingredients
Each 660 mg tablet contains the active substance: praziquantel 50 mg.
Excipients
Lactose, microcrystalline cellulose, polyvinylpyrrolidone, sodium lauryl sulfate, magnesium stearate, colloidal anhydrous silica, maize starch.
Indications
Anthelmintic for dogs and cats, with a specific effect against adult cestodes and immature intestinal forms. It is effective against: Echinococcus granulosus*, Echinococcus multilocularis, Dipylidium caninum, Taenia ovis, Taenia pisiformis, Taenia hydatigena, Mesocestoides corti, Hydatigera (Taenia) taeniaeformis, Taenia multiceps, Diphyllobothrium (Spirometra) erinacei. * Echinococcus granulosus: the dog, as carrier of the Echinococcus tapeworm, becomes infested via sheep, cattle or pigs and can also transmit echinococcosis (hydatidosis, cystic form) to humans, a serious social disease in sheep-farming regions. Therapeutic and/or prophylactic treatment with the veterinary medicine (ideally planned on a large scale) interrupts the parasite's life cycle and prevents transmission to humans. Hydatidosis cycle.
Contraindications/Adverse Effects
Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs weighing less than 2.5 kg.
Safety in Target Species
None known.
Dosage
For oral use. The basic dose for dogs and cats is 5 mg/kg body weight. Therefore: 1 tablet up to 10 kg bw; 2 tablets from 11 to 20 kg; 3 tablets from 21 to 30 kg. Against Diphyllobothrium (Spirometra) a dose of one tablet per 2.5 kg bw is required. Overdoses of up to twice the recommended dose are not harmful, especially when treating massive Echinococcus tapeworm infestations. The veterinary medicine is very well tolerated. In adult animals, doses up to 10 times the recommended dose (5 mg/kg bw) are generally well tolerated. Underdosing could result in ineffective use and may favour the development of resistance. The accuracy of the dose should be carefully checked. Treatment should be given on an empty stomach and animals should be monitored immediately after administration so that treatment can be repeated if the tablets are rejected. The veterinary medicine can be given directly, wrapped in meat, or crushed into food.
Storage
This veterinary medicine does not require any special storage conditions. Shelf life of the veterinary medicine as packaged for sale: 5 years.
Warnings
Fleas act as intermediate hosts and are therefore a source of Dipylidium caninum infection. To avoid reinfection, fleas must be eliminated from the animal and its living quarters. Faeces passed by dogs in the 24 hours following treatment must be collected and destroyed. The possibility that other animals in the same environment may be a source of Dipylidium caninum reinfection should be considered, and these should be treated as necessary with an appropriate product. Unnecessary use of antiparasitics or use deviating from the instructions given in the SPC may increase resistance selection pressure and lead to reduced efficacy. The decision to use the product should be based on confirmation of the parasitic species and burden, or of the risk of infection based on its epidemiological features, for each animal. Special precautions for safe use in the target species: none. Special precautions to be taken by the person administering the veterinary medicine to animals: for proper hygiene, the person administering the product should wash their hands after use. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the doctor. Special precautions for the protection of the environment: not applicable. None known. Incompatibilities: none known.
Withdrawal Periods
Not applicable.
Target Species
Dog and cat.
Interactions
None known.
Diagnosis and Prescription
Veterinary medicine not subject to veterinary prescription.
Adverse Effects
Dogs and cats. Very rare (<1 animal / 10,000 animals treated, including isolated reports): gastrointestinal disorders (e.g. vomiting or diarrhoea). Reporting adverse events is important as it allows continuous monitoring of the safety of a veterinary medicine. Reports should preferably be sent via a veterinary surgeon to the marketing authorisation holder or its local representative, or to the national competent authority via the national reporting system https://www.salute.gov.it/portale/moduliServizi/dettaglioSchedaModuliServizi.jsp? lingua=italiano&label=servizionline&idMat=MDV&idAmb=FMV&idSrv=PSK&flag=P. See also section 16 of the package leaflet for the respective contact details.
Pregnancy and Lactation
Pregnancy and lactation: the veterinary medicine can be used in dogs and cats during pregnancy. Praziquantel is considered safe both for the female animal herself and for the foetus. The safety of the veterinary medicine during lactation has not been established. Use only in accordance with the benefit-risk assessment by the responsible veterinary surgeon.
